Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities

NCT ID: NCT04106583

Last Updated: 2025-03-04

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

572 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-11-05

Study Completion Date

2023-08-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this study is to demonstrate the safety and efficacy of the Penumbra SMART COIL® System, including the WAVE™ Extra Soft Coils (WAVE) as a fill and finish coil, in the treatment of intracranial aneurysms. Imaging will be analyzed by an independent core lab to assess aneurysm occlusion rates and perform a comparative analysis between imaging modalities.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aneurysm, Brain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Single Arm

Single Arm - Patients with intracranial aneurysms treated with WAVE, as part of the Penumbra SMART COIL System

WAVE, as part of the SMART COIL System

Intervention Type DEVICE

WAVE, as part of the SMART COIL System

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

WAVE, as part of the SMART COIL System

WAVE, as part of the SMART COIL System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient age ≥ 18 years
* Patient having embolization of intracranial aneurysms
* WAVE Extra Soft Coil is final finishing coil
* Penumbra SMART COIL System accounts for at least 75% of total number of coils implanted
* Informed consent obtained per Institutional Review Board/Ethics Committee (IRB/EC) requirements

Exclusion Criteria

* Life expectancy less than 1 year
* Patient previously enrolled in the SURF Study
* Known multiple intracranial aneurysms requiring treatment during index procedure
* Patient is unwilling or unable to comply with protocol follow up schedule and/or based on the Investigator's judgment the patient is not a good study candidate
* Participation in an interventional drug or device study that may confound the results of the study
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Penumbra Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Clemens M Schirmer, MD

Role: PRINCIPAL_INVESTIGATOR

Geisinger Clinic

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Southeast Health Medical Center

Dothan, Alabama, United States

Site Status

Banner UMC Tucson

Tucson, Arizona, United States

Site Status

Sharp Grossmont

La Mesa, California, United States

Site Status

Los Robles

Thousand Oaks, California, United States

Site Status

HRI - Swedish

Englewood, Colorado, United States

Site Status

St. Anthony's Hospital

Lakewood, Colorado, United States

Site Status

Yale New Haven

New Haven, Connecticut, United States

Site Status

University of Miami (Jackson Memorial)

Miami, Florida, United States

Site Status

University of South Florida

Tampa, Florida, United States

Site Status

Morton Plant

Tampa, Florida, United States

Site Status

Rush University Medical Center

Chicago, Illinois, United States

Site Status

Amita Health

Joliet, Illinois, United States

Site Status

Indiana University Health

Indianapolis, Indiana, United States

Site Status

Ochsner Medical Center

New Orleans, Louisiana, United States

Site Status

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status

Brigham and Women's Hospital

Boston, Massachusetts, United States

Site Status

Metro Health

Wyoming, Michigan, United States

Site Status

SSM Health Care

Bridgeton, Missouri, United States

Site Status

Northwell Health

Manhasset, New York, United States

Site Status

Mount Sinai Hospital

New York, New York, United States

Site Status

Westchester Medical Center

Valhalla, New York, United States

Site Status

Vidant Medical Center

Greenville, North Carolina, United States

Site Status

Mercy St. Vincent

Toledo, Ohio, United States

Site Status

University of Oklahoma

Oklahoma City, Oklahoma, United States

Site Status

Geisinger Medical Center

Danville, Pennsylvania, United States

Site Status

UPenn

Philadelphia, Pennsylvania, United States

Site Status

Allegheny General Hospital

Pittsburgh, Pennsylvania, United States

Site Status

MUSC

Charleston, South Carolina, United States

Site Status

Greenville Memorial Hospital

Greenville, South Carolina, United States

Site Status

University of Tennessee Medical Center, Knoxville

Knoxville, Tennessee, United States

Site Status

Baylor University Medical Center

Dallas, Texas, United States

Site Status

McAllen Medical Center

McAllen, Texas, United States

Site Status

Texas Stroke Institute - DFW

Plano, Texas, United States

Site Status

Riverside Regional Medical Center

Newport News, Virginia, United States

Site Status

Foothills Medical Center

Calgary, , Canada

Site Status

University Health Network

Toronto, , Canada

Site Status

Bremen-Mitte

Bremen, , Germany

Site Status

Klinikum Chemnitz gGmbH

Chemnitz, , Germany

Site Status

UKSH - Campus Lübeck

Lübeck, , Germany

Site Status

Maggiore della Carità

Novara, , Italy

Site Status

Vall d'Hebron

Barcelona, , Spain

Site Status

Donostia

San Sebastián, , Spain

Site Status

Universitätsspital Basel

Basel, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States Canada Germany Italy Spain Switzerland

References

Explore related publications, articles, or registry entries linked to this study.

Schirmer CM, Yoo AJ, Spiotta AM, Kaminsky I, Alshekhlee A, Starke RM, Nicholson A, Zaidat OO, Bohnstedt B, Psychogios MN, Viets R, Asif KS, Stapleton CJ, Mitha AP, Goren O; SURF Study Investigators. Intracranial aneurysm embolization using Penumbra fill and finish coils: 1-year results of a prospective, real-world, multicenter SURF study. J Neurointerv Surg. 2025 Sep 4:jnis-2025-023633. doi: 10.1136/jnis-2025-023633. Online ahead of print.

Reference Type DERIVED
PMID: 40908130 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CLP 13669

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

A Medical Device to Treat Wide-Neck Brain Aneurysms
NCT05550571 ACTIVE_NOT_RECRUITING NA
Bioabsorbable/Nufairy Coil Application Trial in China
NCT06466564 ACTIVE_NOT_RECRUITING NA
Enterprise 2 Vascular Reconstruction Device
NCT05254067 ENROLLING_BY_INVITATION